Enter multiple symbols separated by commas

Search results for "WPI"



About 8 results. Sort By: Date | Relevance
UPDATE 1-Allergan forecasts 2nd-half revenue above $8 bln

Teva agreed in July to buy Allergan's generic drugs business for $40.5 billion in cash and stock, leaving Allergan to focus on paying down debt and potential "transformational" acquisitions. Allergan has always expanded its portfolio through acquisitions, the latest being a $2.1 billion offer to buy Kythera Biopharmaceuticals Inc in June.
Source: Reuters
Four countries will keep Asia markets tense this week

In another holiday-shortened trading week, investors will remain on their toes amid a barrage of data due from the region's top four economies.
Source: CNBC.com | By: See Kit Tang
Amgen, Allergan say Avastin copycat succeeds in lung cancer study

Sept 23- Amgen Inc and Allergan Plc said their drug candidate for lung cancer was found as effective as Roche AG's Avastin in preventing disease progression and improving survival, in a late-stage study. The drug, ABP 215, is being developed as a biosimilar to Avastin. Biosimilars are copied versions of a biotechnology drug.
Source: Reuters
Allergan gets FDA nod for new antipsychotic

Sept 17- Allergan Plc said on Thursday the U.S. Food and Drug Administration approved its new antipsychotic drug to treat bipolar disorder and schizophrenia. The new drug will be the second antipsychotic to be sold by Allergan. Allergan partnered Gedeon Richter Plc to develop Vraylar.
Source: Reuters
China stocks close sharply down on data, Fed uncertainty

Asian stocks put up a mixed performance on Monday, as traders digest a slew of Chinese data and tread cautiously ahead of the Fed's policy meeting this week.
Source: CNBC.com | By: See Kit Tang
Fed-watch: Will volatility return with a vengeance?

The key question plaguing investors may finally see an answer this week, when the Fed meets for a two-day meeting on Wednesday.
Source: CNBC.com | By: See Kit Tang
Bellafill dermal filler effective 5 years after treatment-study

The dermal filler, made primarily of bovine collagen, has been approved by the U.S. Food and Drug Administration for smoothening "laugh lines" since 2006 and for treating acne scarring of the cheek since January this year. In 2013 alone, there were more than 2.2 million injectable filler procedures in the United States, according to the American Society of Plastic...
Source: Reuters
UPDATE 1-Pfizer loses UK patent case over use of Lyrica drug in pain

LONDON, Sept 10- Pfizer suffered a major setback in Britain on Thursday when the High Court in London ruled that claims of patent protection for the use of its $5 billion- a-year drug Lyrica as a pain treatment were invalid. While the original patent on pregabalin expired last year, Pfizer was awarded a secondary patent covering pain, valid until July 2017, and the...
Source: Reuters | By: Ben Hirschler